Skip to main content
Fig. 3 | Diagnostic Pathology

Fig. 3

From: DNA damage response and repair gene mutations are associated with tumor mutational burden and outcomes to platinum-based chemotherapy/immunotherapy in advanced NSCLC patients

Fig. 3

Association between DDR gene mutations and clinical outcomes to platinum-based chemotherapy and platinum-based chemotherapy/immunotherapy. (A) Association between DDR mutations and ORR in patients receiving platinum-based chemotherapy. (B) Association between DDR mutations and DCR in patients receiving platinum-based chemotherapy. (C) Association between DDR mutations and ORR in patients receiving platinum-based chemotherapy/immunotherapy. (D) Association between DDR mutations and DCR in patients receiving platinum-based chemotherapy/immunotherapy. ORR: objective response rate, DCR: disease control rate

Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us